Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Los receptores epidérmicos humanos en el cáncer gástrico: alteraciones moleculares y su papel como diana terapéutica.

Gaceta medica de Mexico - 1 Jan 2000

Bustos-Carpinteyro Andrea Rebeca, Magaña-Torres María Teresa, González-García Juan Ramón, Torres-Jasso Juan Heriberto, Sánchez-López Josefina Yoaly

Abstract excerpt

Gastric cancer (GC) is the third leading cause of cancer death worldwide; both environmental and genetic factors are involved in the etiology of this neoplasia. The human epidermal receptor (HER) pathway is essential for proliferation and differentiation of normal cells; but it is also implicated in the growth of cancer cells. In this work we investigate the molecular alterations in genes that encodes for HER...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antineoplastic Agents, Immunological

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, erbB-2

Share to Receptor, ErbB-2

Share to Receptor, ErbB-3

Share to Receptor, ErbB-4

Share to Stomach Neoplasms

Share to Trastuzumab

Source

Identifiers

PMID: 29414960
DOI: 10.24875/GMM.17002748

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Los receptores epidérmicos humanos en el cáncer gástrico: alteraciones moleculares y su papel como diana terapéutica.PMID 29414960Read ↗

Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor OutcomeSemantic proximity Read ↗

Molecular biology of human epidermal receptors, signaling pathways and targeted therapy against cancers: new evidences and old challengesSemantic proximity Read ↗

Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part II: Targeting gene mutations and gene amplifications and the angiogenesis pathway.Semantic proximity Read ↗

Expression of the EGF Family in Gastric Cancer: Downregulation of HER4 and Its Activating Ligand NRG4Semantic proximity Read ↗

Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibitionSemantic proximity Read ↗

Estrogen receptors in gastric cancer: Advances and perspectivesSemantic proximity Read ↗

Epidermal growth factor receptor structural alterations in gastric cancer.Semantic proximity Read ↗

Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancerSemantic proximity Read ↗

The genomics and therapeutics of HER2-positive gastric cancer—from trastuzumab and beyondSemantic proximity Read ↗

Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survivalSemantic proximity Read ↗

Significance and prognostic role of human epidermal growth factor receptor 2 and RAB1A expression in gastric cancerSemantic proximity Read ↗

Epidermal growth factor receptor expression in gastric tumors and its relationship with the germline polymorphisms - 216 G>T, -191 C>A, (CA) n IVS1, and R521K.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.